En pacientes con carcinoma orofaríngeo de células escamosas la protonterapia se asocia con una mayor tasa de osteorradionecrosis que la radioterapia de intensidad modulada, particularmente en el tipo definitivo, aunque la de alto grado sigue siendo rara #OPSCC #ORN jamanetwork.com/journals/jam...
Osteoradionecrosis After Radiotherapy for Oropharyngeal Carcinoma
This cohort study characterizes the incidence, severity, and predictors of osteoradionecrosis in patients with oropharyngeal squamous cell carcinoma treated with curative-intent radiotherapy and compa...
jamanetwork.com
December 10, 2025 at 1:30 PM
En pacientes con carcinoma orofaríngeo de células escamosas la protonterapia se asocia con una mayor tasa de osteorradionecrosis que la radioterapia de intensidad modulada, particularmente en el tipo definitivo, aunque la de alto grado sigue siendo rara #OPSCC #ORN jamanetwork.com/journals/jam...
This heterogeneity highlights the need for more standardized, large-scale, and mechanistic investigations to fully understand the microbiome's influence on OPSCC. Limitations include the diverse methodologies and patient populations across the included studies.
September 29, 2025 at 10:56 PM
This heterogeneity highlights the need for more standardized, large-scale, and mechanistic investigations to fully understand the microbiome's influence on OPSCC. Limitations include the diverse methodologies and patient populations across the included studies.
While increases in certain bacteria like Porphyromonas gingivalis, Tannerella forsythia, and Fusobacterium were observed in OPSCC patients, no consistent microbial signatures were identified across studies.
September 29, 2025 at 10:56 PM
While increases in certain bacteria like Porphyromonas gingivalis, Tannerella forsythia, and Fusobacterium were observed in OPSCC patients, no consistent microbial signatures were identified across studies.
This systematic review examined the role of the oral/oropharyngeal microbiome in the development and prognosis of oropharyngeal squamous cell carcinoma (OPSCC).
September 29, 2025 at 10:56 PM
This systematic review examined the role of the oral/oropharyngeal microbiome in the development and prognosis of oropharyngeal squamous cell carcinoma (OPSCC).
SDBN Trending: BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA https://zpr.io/NquKbp7kmcUD
September 9, 2025 at 9:27 AM
SDBN Trending: BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA https://zpr.io/NquKbp7kmcUD
Daha az toksik kanser tedavisi HPV+OPSCC için kür oranlarını korur.
Mevcut tedaviler yüksek toksisiteleri nedeniyle genellikle önemli uzun vadeli yan etkilere yol açar.
newsnetwork.mayoclinic.org/discussion/s...
Mevcut tedaviler yüksek toksisiteleri nedeniyle genellikle önemli uzun vadeli yan etkilere yol açar.
newsnetwork.mayoclinic.org/discussion/s...
September 4, 2025 at 8:34 AM
Daha az toksik kanser tedavisi HPV+OPSCC için kür oranlarını korur.
Mevcut tedaviler yüksek toksisiteleri nedeniyle genellikle önemli uzun vadeli yan etkilere yol açar.
newsnetwork.mayoclinic.org/discussion/s...
Mevcut tedaviler yüksek toksisiteleri nedeniyle genellikle önemli uzun vadeli yan etkilere yol açar.
newsnetwork.mayoclinic.org/discussion/s...
Shorter, Milder Radiation-Chemo Effective for HPV-Linked Oropharyngeal Cancer, Mayo Study Finds
A groundbreaking study from the renowned Mayo Clinic has unveiled a transformative approach to treating HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC), heralding a new era in cancer…
A groundbreaking study from the renowned Mayo Clinic has unveiled a transformative approach to treating HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC), heralding a new era in cancer…
Shorter, Milder Radiation-Chemo Effective for HPV-Linked Oropharyngeal Cancer, Mayo Study Finds
A groundbreaking study from the renowned Mayo Clinic has unveiled a transformative approach to treating HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC), heralding a new era in cancer therapy. This research demonstrates that a significantly shortened and less intense regimen of radiation combined with chemotherapy, administered following minimally invasive surgery, can dramatically reduce treatment-related toxicities without compromising efficacy. Published in the prestigious journal…
scienmag.com
September 2, 2025 at 5:30 PM
Shorter, Milder Radiation-Chemo Effective for HPV-Linked Oropharyngeal Cancer, Mayo Study Finds
A groundbreaking study from the renowned Mayo Clinic has unveiled a transformative approach to treating HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC), heralding a new era in cancer…
A groundbreaking study from the renowned Mayo Clinic has unveiled a transformative approach to treating HPV-positive oropharyngeal squamous cell carcinoma (HPV+OPSCC), heralding a new era in cancer…
Spotlight on Perfusion: Reshaping Oropharyngeal Squamous Cell Carcinoma Surgery
#perfusionassessment #opscc #headandnecksurgery #icg #icgreen #diagnosticgreen
diagnosticgreen.com/am/news/icg-...
#perfusionassessment #opscc #headandnecksurgery #icg #icgreen #diagnosticgreen
diagnosticgreen.com/am/news/icg-...
ICG-Guided Surgery in Oropharyngeal Cancer
ICG fluorescence-guided surgery boosts precision and safety in OPSCC resection, aiding real-time perfusion assessment and reconstruction.
diagnosticgreen.com
August 19, 2025 at 9:08 AM
Spotlight on Perfusion: Reshaping Oropharyngeal Squamous Cell Carcinoma Surgery
#perfusionassessment #opscc #headandnecksurgery #icg #icgreen #diagnosticgreen
diagnosticgreen.com/am/news/icg-...
#perfusionassessment #opscc #headandnecksurgery #icg #icgreen #diagnosticgreen
diagnosticgreen.com/am/news/icg-...
Becker's Hospital Review spotlights the CAP's guideline on HPV testing in head & neck cancers.
Routine testing using p16 is now recommended for all OPSCC cases to improve treatment decisions. brnw.ch/21wSRsS
#HPV #HeadNeckCancer
Routine testing using p16 is now recommended for all OPSCC cases to improve treatment decisions. brnw.ch/21wSRsS
#HPV #HeadNeckCancer
May 23, 2025 at 2:15 PM
Becker's Hospital Review spotlights the CAP's guideline on HPV testing in head & neck cancers.
Routine testing using p16 is now recommended for all OPSCC cases to improve treatment decisions. brnw.ch/21wSRsS
#HPV #HeadNeckCancer
Routine testing using p16 is now recommended for all OPSCC cases to improve treatment decisions. brnw.ch/21wSRsS
#HPV #HeadNeckCancer
NCI blog patient story for trial NCT06223568 #neoadjuvant chemo (cisplatin&docetaxel) & #HPV #immunotherapy (PRGN-2009) for newly diagnosed HPV-positive OPSCC (PI Dr Clint Allen): omission of adjuvant radiotherapy per response to neoadj Tx & surg path risk factors.
ccr.cancer.gov/news/article...
ccr.cancer.gov/news/article...
Offering “life-sustaining” treatment without compromising quality of life | Center for Cancer Research
When Alison James received her diagnosis of squamous cell carcinoma, she was alarmed by the side effects associated with the standard of care. She traveled to the NIH Clinical Center for a CCR clinica...
ccr.cancer.gov
May 2, 2025 at 4:24 PM
NCI blog patient story for trial NCT06223568 #neoadjuvant chemo (cisplatin&docetaxel) & #HPV #immunotherapy (PRGN-2009) for newly diagnosed HPV-positive OPSCC (PI Dr Clint Allen): omission of adjuvant radiotherapy per response to neoadj Tx & surg path risk factors.
ccr.cancer.gov/news/article...
ccr.cancer.gov/news/article...
Unlike cervical cancer, 𝐭𝐡𝐞𝐫𝐞’𝐬 𝐧𝐨 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 for OPSCC. That means: 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐢𝐬 𝐤𝐞𝐲.
💉 All genders age ≤26 yrs should be vaccinated
💉 Adults ages 27–45 yrs may benefit too
💬 Let’s normalize HPV conversations beyond cervical cancer
📢 Raise awareness of vaccine-preventable cancer
#MedSky
💉 All genders age ≤26 yrs should be vaccinated
💉 Adults ages 27–45 yrs may benefit too
💬 Let’s normalize HPV conversations beyond cervical cancer
📢 Raise awareness of vaccine-preventable cancer
#MedSky
April 1, 2025 at 10:21 AM
Unlike cervical cancer, 𝐭𝐡𝐞𝐫𝐞’𝐬 𝐧𝐨 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 for OPSCC. That means: 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐢𝐬 𝐤𝐞𝐲.
💉 All genders age ≤26 yrs should be vaccinated
💉 Adults ages 27–45 yrs may benefit too
💬 Let’s normalize HPV conversations beyond cervical cancer
📢 Raise awareness of vaccine-preventable cancer
#MedSky
💉 All genders age ≤26 yrs should be vaccinated
💉 Adults ages 27–45 yrs may benefit too
💬 Let’s normalize HPV conversations beyond cervical cancer
📢 Raise awareness of vaccine-preventable cancer
#MedSky
📆 𝐀𝐩𝐫𝐢𝐥 𝐢𝐬 𝐎𝐫𝐚𝐥, 𝐇𝐞𝐚𝐝 & 𝐍𝐞𝐜𝐤 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 🎗️
𝐓𝐡𝐫𝐨𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 (OPSCC) is now the most common HPV-associated cancer in 🇨🇦 + 🇺🇸—surpassing cervical cancer.
But public awareness is low:
🔹 Only 30% know HPV can cause it
🔹 𝐌𝐞𝐧—esp. those who perform oral sex (on men or women)—are more at risk
𝐓𝐡𝐫𝐨𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 (OPSCC) is now the most common HPV-associated cancer in 🇨🇦 + 🇺🇸—surpassing cervical cancer.
But public awareness is low:
🔹 Only 30% know HPV can cause it
🔹 𝐌𝐞𝐧—esp. those who perform oral sex (on men or women)—are more at risk
April 1, 2025 at 10:21 AM
📆 𝐀𝐩𝐫𝐢𝐥 𝐢𝐬 𝐎𝐫𝐚𝐥, 𝐇𝐞𝐚𝐝 & 𝐍𝐞𝐜𝐤 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 🎗️
𝐓𝐡𝐫𝐨𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 (OPSCC) is now the most common HPV-associated cancer in 🇨🇦 + 🇺🇸—surpassing cervical cancer.
But public awareness is low:
🔹 Only 30% know HPV can cause it
🔹 𝐌𝐞𝐧—esp. those who perform oral sex (on men or women)—are more at risk
𝐓𝐡𝐫𝐨𝐚𝐭 𝐜𝐚𝐧𝐜𝐞𝐫 (OPSCC) is now the most common HPV-associated cancer in 🇨🇦 + 🇺🇸—surpassing cervical cancer.
But public awareness is low:
🔹 Only 30% know HPV can cause it
🔹 𝐌𝐞𝐧—esp. those who perform oral sex (on men or women)—are more at risk
The incidence of oropharyngeal squamous cell carcinoma (OPSCC) in men has surpassed that of cervical cancer in the UK. www.thelancet.com/journals/lan...
Rapidly rising rates of oropharyngeal cancer and economic burden in the UK
Despite introducing the human papillomavirus (HPV) vaccination for boys aged 12–13
years in the UK in 2019, uptake remains limited in many regions, including London.1,2
The incidence of oropharyngeal ...
www.thelancet.com
March 28, 2025 at 5:42 PM
The incidence of oropharyngeal squamous cell carcinoma (OPSCC) in men has surpassed that of cervical cancer in the UK. www.thelancet.com/journals/lan...
I got diagnosed OPSCC base of my tongue last year. Brutal chemo and radiation regimen but seems to have worked. Science matters. Vaccines matter. #Healthcare
November 19, 2024 at 1:05 PM
I got diagnosed OPSCC base of my tongue last year. Brutal chemo and radiation regimen but seems to have worked. Science matters. Vaccines matter. #Healthcare
When raising awareness of rare cancers we have to choose our audience carefully. Which is why I've developed 2 training programs for GPs worth CPD pts. My latest blog explains the HPV+ OPSCC training modules & response so far #gptraining #headandneckcancer
https://www.richardgallagher.com.au/...
https://www.richardgallagher.com.au/...
November 25, 2024 at 12:45 AM
When raising awareness of rare cancers we have to choose our audience carefully. Which is why I've developed 2 training programs for GPs worth CPD pts. My latest blog explains the HPV+ OPSCC training modules & response so far #gptraining #headandneckcancer
https://www.richardgallagher.com.au/...
https://www.richardgallagher.com.au/...
Another question from #GPCESydney, what does 10 year survival look like for HPV+ OPSCC patients? Patients are cured at 5 years. They are at risk of developing second cancers, but the risk is lower for HPV+ OPSCC patients than HPV- patients. Overall, the outlook is good #HNCancer
November 25, 2024 at 12:45 AM
Another question from #GPCESydney, what does 10 year survival look like for HPV+ OPSCC patients? Patients are cured at 5 years. They are at risk of developing second cancers, but the risk is lower for HPV+ OPSCC patients than HPV- patients. Overall, the outlook is good #HNCancer
When discussing sexual history as a risk for HPV+ OPSCC, why is no. of sexual partners important? Truth is, you could be unlucky, only need one HPV infection, but evidence suggests volume of sexual partners means repeated HPV infection & increased risk #HNCancer #GPCESydney
November 25, 2024 at 12:45 AM
When discussing sexual history as a risk for HPV+ OPSCC, why is no. of sexual partners important? Truth is, you could be unlucky, only need one HPV infection, but evidence suggests volume of sexual partners means repeated HPV infection & increased risk #HNCancer #GPCESydney
Waiting 40 weeks for a cancer diagnosis. My latest blog describes patient stories of delayed diagnosis of HPV+ OPSCC. It coincides with our study due for publication in the next issue of ANZ Journal of Surgery #headandneckcancer #throatcancer https://www.richardgallagher.com.au/news/waiting-40-we...
November 25, 2024 at 12:46 AM
Waiting 40 weeks for a cancer diagnosis. My latest blog describes patient stories of delayed diagnosis of HPV+ OPSCC. It coincides with our study due for publication in the next issue of ANZ Journal of Surgery #headandneckcancer #throatcancer https://www.richardgallagher.com.au/news/waiting-40-we...
Innovative study led by @DrNeilGross demonstrates a new role of immunotherapy prior to TORS for OPSCC. A great strategy for the benefit of patients. #roboticsurgery @drjuliaENT @Thyroid_Surgeon @scottmagnusonmd @ywkohent
November 25, 2024 at 12:48 AM
Innovative study led by @DrNeilGross demonstrates a new role of immunotherapy prior to TORS for OPSCC. A great strategy for the benefit of patients. #roboticsurgery @drjuliaENT @Thyroid_Surgeon @scottmagnusonmd @ywkohent
Looking forward to welcoming GP’s to our open evening on Level 14 and sharing information about HPV+ OPSCC. Free viruses for everyone #HPV @svphs @SVHSydney @AirwaySurgeon @lisasamzig @tahnee_walshaw
November 25, 2024 at 12:50 AM
Looking forward to welcoming GP’s to our open evening on Level 14 and sharing information about HPV+ OPSCC. Free viruses for everyone #HPV @svphs @SVHSydney @AirwaySurgeon @lisasamzig @tahnee_walshaw